Antibiotic News and Research

RSS

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.

Antibiotics have sex-specific effects on the gut microbiome, preclinical study finds

In a new study, researchers at Cedars-Sinai found that antibiotics have sex-specific effects on the gut microbiome makeup of male and female laboratory rats. The findings, published in the journal Frontiers in Microbiology, could have implications for using the drugs in humans to treat or prevent bacterial infection.

20 Jul 2022

Cholera variants need to be monitored closely to prevent outbreaks, scientists urge

Cholera variants are constantly evolving and need to be monitored closely to prevent outbreaks, say researchers.

20 Jul 2022

Scientists manipulate good bacteria using CRISPR systems

New North Carolina State University research shows progress in gathering information on an important – yet difficult to characterize – human gut bacterium called Bifidobacterium, which is used in many probiotics that help maintain healthy microbiomes.

19 Jul 2022

The state of antimicrobial resistance in the United States immediately following the 2020 peaks of the COVID-19 pandemic

Researchers assessed the impact of COVID-19 on antimicrobial resistance.

18 Jul 2022

COVID-19 risks may be heightened by history of Lyme disease

Individuals with a history of Lyme disease, caused by tick bites are at a higher risk of severe COVID-19.

17 Jul 2022

Proteins' wobbles, shakes and quivers play a key role in their ability to function

Johns Hopkins Medicine scientists report they have probed the atomic structure of proteins to add to evidence that the wobbles, shakes and quivers of proteins play a critical role in their ability to function.

15 Jul 2022

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Forget covid-19, monkeypox, and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and even hospitalizations because of the failure of oral antibiotics.

15 Jul 2022

Acknowledging AMR in regulatory frameworks for drug approvals could improve the availability of new antibiotics

The appropriate use of existing antibiotics and the development of new antibiotics targeting drug-resistant infections can slow the emergence, spread, and consequences of antimicrobial resistance (AMR); however, antibiotic research and development (R&D) has not responded to the urgent need for new antibiotics.

15 Jul 2022

COVID-19 pandemic pushes back years of progress made in fighting antimicrobial resistance

The COVID-19 pandemic pushed back years of progress made in combating antimicrobial resistance (AR) in the United States.

14 Jul 2022

Bioactive compounds in a marine sponge show potential to kill antibiotic-resistant bacteria

A research group led by scientists at the University of São Paulo (USP) in São Carlos, Brazil, has identified a number of bioactive compounds in a marine sponge collected on Fernando de Noronha, an archipelago about 400 km off the coast of Brazil's Northeast region.

13 Jul 2022

Infection in early life can increase a baby's sensitivity to pain

Researchers from Oxford's Department of Pediatrics have discovered that infection can increase a baby's sensitivity to pain, which may last longer than the infection.

12 Jul 2022

Diabetes not strongly associated with in-hospital COVID mortality

In a recent study posted to the medRxiv* preprint server, researchers assessed the association between diabetes mellitus (type 2 diabetes) and mortality among patients hospitalized with coronavirus disease 2019 (COVID-19) at multiple centers in Canada and Denmark.

8 Jul 2022

Researchers unravel mechanism that underlies failure of staph vaccine trials

For the most part, the bacterium Staphylococcus aureus is common and harmless, posing no threat to humans with whom they coexist.

7 Jul 2022

2022 monkeypox presents with new symptoms

In a recent study published in The Lancet Infectious Diseases, researchers described the clinical and demographical characteristics of monkeypox virus infections among individuals attending sexual health centers in the United Kingdom (UK).

6 Jul 2022

Study: Lactobacilli living in female urinary tract's microbiome can kill nearby pathogenic bacteria

Lactobacilli that live in the human female urinary tract's microbiome are competitive and kill nearby pathogenic bacteria, according to the first study of its kind by a team led by microbiologist Dr. Tanya Sysoeva of The University of Alabama in Huntsville.

6 Jul 2022

Outpatient antibiotic management of patients with appendicitis is safe, helps avoid surgery

Outpatient antibiotic management of selected patients with appendicitis is safe, allowing many patients to avoid surgery and hospitalization, and should be considered as part of shared decision-making between doctor and patient.

6 Jul 2022

What role does human microbiota play in COVID-19 severity?

In a recent study published in the journal Advanced Science, researchers explored the dynamic changes in the respiratory tract and gut microbiota in coronavirus disease 2019 (COVID-19) patients. They observed and analyzed these changes during different disease progression stages among patients with differential disease severities.

5 Jul 2022

New study discloses the reason behind the disappearance of highly infectious cholera variant

A new study reveals why a highly infectious variant of the cholera bug, which caused large disease outbreaks in the early 1990s, did not cause the eighth cholera pandemic as feared – but instead unexpectedly disappeared.

5 Jul 2022

Stopping a pervasive bacterium that makes millions sick each year

As we head outdoors this summer, scientists are working to clip the long, flexible appendages that enable the common bacterium Campylobacter jejuni to make its way from undercooked poultry and natural waterways into our intestinal tract where it makes millions of us sick each year.

1 Jul 2022

Review sheds light on the emergence and detection of antibiotic resistance in bioaerosols

Bioaerosols, or airborne biological particles containing viruses, fungal spores, bacteria, and pollen, play a key role in public health. Antibiotic resistance (AR), caused by antibiotic resistance genes (ARGs), could potentially cause global public health crises owing to horizontal gene transfer between same or similar bacterial bioaerosols.

30 Jun 2022

Antibiotic News and Research

Further Reading

Antibiotics have sex-specific effects on the gut microbiome, preclinical study finds

Cholera variants need to be monitored closely to prevent outbreaks, scientists urge

Scientists manipulate good bacteria using CRISPR systems

The state of antimicrobial resistance in the United States immediately following the 2020 peaks of the COVID-19 pandemic

COVID-19 risks may be heightened by history of Lyme disease

Proteins' wobbles, shakes and quivers play a key role in their ability to function

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Acknowledging AMR in regulatory frameworks for drug approvals could improve the availability of new antibiotics

COVID-19 pandemic pushes back years of progress made in fighting antimicrobial resistance

Bioactive compounds in a marine sponge show potential to kill antibiotic-resistant bacteria

Infection in early life can increase a baby's sensitivity to pain

Diabetes not strongly associated with in-hospital COVID mortality

Researchers unravel mechanism that underlies failure of staph vaccine trials

2022 monkeypox presents with new symptoms

Study: Lactobacilli living in female urinary tract's microbiome can kill nearby pathogenic bacteria

Outpatient antibiotic management of patients with appendicitis is safe, helps avoid surgery

What role does human microbiota play in COVID-19 severity?

New study discloses the reason behind the disappearance of highly infectious cholera variant

Stopping a pervasive bacterium that makes millions sick each year

Review sheds light on the emergence and detection of antibiotic resistance in bioaerosols

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News